EQT Acquires Majority Stake in Adalvo from Aztiq to Fuel Global Expansion

Adalvo was founded in 2018 by Aztiq and is one of the leading business-to-business pharmaceutical companies in Europe EQT will support Adalvo’s ...

July 21, 2025 | Monday | News
FDA Halts Sarepta’s Gene Therapy Trials After Deaths; Platform Designation Revoked Amid Safety Concerns

The U.S. Food and Drug Administration announced it has placed Sarepta Therapeutics investigational gene therapy clinical trials for limb girdle muscular ...

July 21, 2025 | Monday | Regulatory
Rare Voices, Real Impact as Alexion Humanises Rare Disease Care

In this BioPharma Boardroom discussion, we speak with Christophe Hotermans, Head of Global Medical Affairs at Alexion, AstraZeneca Rare Disease. From the e...

July 21, 2025 | Monday | Interaction
Korean Study Reveals Toxic Effects of Airborne Fungi at Levels Below Current Guidelines

Airborne microorganisms, including fungi and bacteria, are major contributors to indoor air pollution, with growing links to respiratory diseases. In a r...

July 18, 2025 | Friday | Reports
Thermo Fisher to Acquire Sanofi’s Steriles Manufacturing Site in Ridgefield to Expand U.S. Drug Production Capabilities

Thermo Fisher to Acquire Sanofi’s Steriles Manufacturing Site in Ridgefield, New Jersey to Produce Critical Medicines for Sanofi Enables Additiona...

July 17, 2025 | Thursday | News
Qosina Expands Distribution Partnership with Saint-Gobain, Adding 38 New Tubing SKUs to Support Bioprocessing Needs

Qosina, a leading global supplier of OEM single-use components to the medical and bioprocess industries, is pleased to announce the expansion of its part...

July 17, 2025 | Thursday | News
Amphista Therapeutics Reaches Discovery Milestone in Merck Collaboration for Next-Gen Protein Degraders

Amphista Therapeutics (“the Company” or “Amphista”), a leader in the discovery of next-generation, Targeted Protein Degradation (...

July 17, 2025 | Thursday | News
Thermo Fisher Launches Rapid CGP Solution on Genexus System to Advance Precision Oncology

Thermo Fisher Scientific announced that the Oncomine™ Comprehensive Assay Plus* is now available on the Ion Torrent™ Genexus™ System* h...

July 15, 2025 | Tuesday | News
Waters and BD Strike $17.5B Strategic Combination

Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters' proven execution...

July 15, 2025 | Tuesday | News
Ultragenyx Receives Complete Response Letter from FDA for UX111 Gene Therapy for Sanfilippo Syndrome Type A

Ultragenyx Pharmaceutical Inc. announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for its Biologics L...

July 14, 2025 | Monday | News
CARsgen Secures Final EPO Win for GPC3 CAR-T Patent After Appeal Withdrawal

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces a favorable outco...

July 14, 2025 | Monday | News
Secarna and Vect-Horus Join Forces to Unlock RNA Therapeutics for CNS Disorders

  The partnership combines Secarna’s OligoCreator® technology with Vect-Horus’ VECTrans® platform to enable system...

July 11, 2025 | Friday | News
Ascentage Pharma Secures China’s First Approval for Bcl-2 Inhibitor in CLL/SLL with Lisaftoclax

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it...

July 11, 2025 | Friday | News
Longeveron Receives FDA Clearance to Begin Phase 2 Trial of Stem Cell Therapy for Pediatric Dilated Cardiomyopathy

 Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and...

July 09, 2025 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close